Published in

Oxford University Press (OUP), Clinical Infectious Diseases, 1(73), p. e256-e259, 2020

DOI: 10.1093/cid/ciaa1361

Links

Tools

Export citation

Search in Google Scholar

Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey

Journal article published in 2020 by Jakko van Ingen ORCID, Stefano Aliberti, Claire Andrejak, James D. Chalmers, Luigi R. Codecasa, Charles L. Daley, Naoki Hasegawa, David E. Griffith, Wouter Hoefsloot, Gwen Huitt, Julie Jarand, Byung Woo Jhun, Michael R. Loebinger, Theodore K. Marras, Kozo Morimoto and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Abstract Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions.